Creative Biolabs Provides Comprehensive Products for CAR-T Therapy
New York, USA – Creative Biolabs, a service provider specialized in Chimeric Antigen Receptor T (CAR-T) cell therapy, provides a comprehensive list of high-quality products for CAR-T/TCR-T Cell Therapy.
CAR-T therapy is widely regarded as one of the most potential method to treat numerous diseases, especially cancers. There are a number of researches that have proven the practicability of CAR-T therapy.
As an expert in CAR-T therapy field, Creative Biolabs is not only specialized in one-stop CAR-T therapy development services but also provides a large inventory of CAR-T products, which includes numerous antigen targets for different diseases such as Leukemia, Lymphoma, Kits for CARs/TCRs Development, Immune Cell Products, Jurkat Cell Products.
1. Anti-CD19 CAR Products
Cluster of Differentiation 19 (CD19) have highly conserved expression on most B cell tumors and are expressed in most acute lymphoblastic leukemias (ALL), chronic lymphocytic leukemias (CLL) and B cell lymphomas, with up to over 80% expression level. Therefore, CD19 is a potential target that will be widely used for therapies of lymphoma, leukemia and autoimmune disorders.
Products: Anti-CD19 scFv h(CD28) CARNK; Murinized anti-CD19 T cell receptor (CBL-Z007); Mouse anti-CD19 T cell receptor (CBL-Z015); Lenti-CD19 CAR (scFv-CD28, FMC63) Viral Particle…
2. Anti-CD44v6 CAR Products
CD44v6 that contains the variant Exon 6 are closely related to tumor growth, invasion, metastasis, and recurrence, especially for breast cancer tumorigenesis and metastasis, and poor patient prognosis.
Products: Anti-CD44v6 h(CD28-CD3ζ, LNGFR) Marked CAR, CD44v6 Recombinant Antibodies…
3. Anti-MUC1 CAR Products
Mucin 1 (MUC1) is a glycoprotein with extensive O-linked glycosylation of its extracellular domain, with overexpression in multiple epithelial cancers, which is also concerned with disease progression.
Products: Anti-MUC1 scFv h(CD28) CART, Lenti-MUC1 CAR (scFv-CD28, SM3) Viral Particle, Mouse Anti-MUC1 DNA-encoded mAb (126E7), MUC1 Recombinant Antibodies…
“Our team has accumulated rich experience in CAR-T field during the past years. We keep on enhancing our technology platform and expanding our product lists in the hope of covering global client needs as much as possible,” said the manager at Creative Biolabs.
More information on CAR-T therapy can be found at https://www.creative-biolabs.com/car-t.
About Creative Biolabs
Creative Biolabs was founded by scientists who are dedicated to the treatment of a wide variety of diseases, including immune disorders, cancers, infections and more. Over the last 10 years, Creative Biolabs has becoming a leader of recombinant antibody (rAb) discovery and manufacturing, providing high quality service to customers in academia and industry fields all over the world. The cutting-edge hybridoma development and phage display platforms allow the production of the most comprehensive list of recombinant antibody products and extensive service portfolio at the most competitive price.
Media Contact
Company Name: Creative Biolabs
Contact Person: Candy Swift
Email: Send Email
Phone: 1-631-619-7922
Country: United States
Website: https://www.creative-biolabs.com/car-t
